Want to see HK:8512 full AI Analyst Report?
Top Page
Hyfusin Group Holdings Ltd.
(8512)
Select Model
Select Model
Rating:73Outperform
Price Target:
HK$0.41
▲(19.71% Upside)
Action:Reiterated
Date:09/25/26
The score is supported mainly by strong financial stability (very low leverage) and an inexpensive valuation (P/E ~3.96). Offsetting these positives are weaker recent profitability versus prior years and softer technical momentum, which together limit upside conviction.
Positive Factors
Very Low Leverage
Minimal leverage gives Hyfusin a substantial capital cushion and limits the burden of interest and refinancing obligations. This supports resilience through weaker operating periods and preserves capacity to fund investment or manage working-capital needs without relying heavily on additional borrowing.
Negative Factors
Margin Compression
The sharp decline in net margin shows that higher costs and/or pricing pressure are absorbing more of the company’s revenue. Even with sales growth, continued margin erosion would limit earnings expansion, reduce reinvestment capacity, and weaken the durability of profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Very Low Leverage
Minimal leverage gives Hyfusin a substantial capital cushion and limits the burden of interest and refinancing obligations. This supports resilience through weaker operating periods and preserves capacity to fund investment or manage working-capital needs without relying heavily on additional borrowing.
Read all positive factors
Hyfusin Group Holdings Ltd. (8512) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$330.66M
Dividend YieldN/A
Average Volume (3M)311.33K
Price to Earnings (P/E)3.9
Beta (1Y)0.45
Revenue Growth-0.33%
EPS Growth-37.85%
CountryHK
Employees1,200
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.09
Shares Outstanding918,500,000
10 Day Avg. Volume522,000
30 Day Avg. Volume311,333
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)0.41
Price to Sales (P/S)0.34
P/FCF Ratio2.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hyfusin Group Holdings Ltd. Business Overview & Revenue Model
Company Description
Operating as an investment holding company, Hyfusin Group Holdings Limited specializes in the creation, manufacturing, and worldwide distribution of candle products, prominently serving markets in the United States and the United Kingdom. Their co...
How the Company Makes Money
Detailed, source-verifiable information on Hyfusin Group Holdings Ltd.'s revenue model and key revenue streams (e.g., specific service lines, customer types, contract structures, and named partnerships) is not available in the provided context; th...
Hyfusin Group Holdings Ltd. Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
86
Very Positive
Cash Flow
68
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.04B | 898.11M | 909.45M | 866.25M | 684.95M | 815.14M |
| Gross Profit | 316.67M | 283.94M | 351.90M | 335.54M | 207.69M | 269.92M |
| EBITDA | 159.25M | 160.42M | 182.16M | 162.15M | 109.57M | 141.47M |
| Net Income | 85.70M | 101.47M | 171.43M | 102.29M | 73.06M | 106.21M |
Balance Sheet | ||||||
| Total Assets | 963.06M | 861.15M | 796.79M | 686.92M | 501.32M | 482.98M |
| Cash, Cash Equivalents and Short-Term Investments | 367.94M | 405.64M | 324.51M | 336.77M | 171.35M | 138.35M |
| Total Debt | 35.85M | 12.23M | 16.43M | 18.36M | 53.96M | 65.94M |
| Total Liabilities | 195.02M | 112.69M | 149.81M | 181.35M | 98.06M | 152.53M |
| Stockholders Equity | 768.04M | 748.46M | 646.97M | 505.57M | 403.26M | 330.46M |
Cash Flow | ||||||
| Free Cash Flow | 133.09M | 140.82M | 36.15M | 213.65M | 59.28M | 19.21M |
| Operating Cash Flow | 189.00M | 202.08M | 101.12M | 248.56M | 96.61M | 73.30M |
| Investing Cash Flow | -48.71M | -46.54M | -51.35M | -31.15M | -39.03M | -60.12M |
| Financing Cash Flow | -97.44M | -74.41M | -62.03M | -51.99M | -24.57M | 16.24M |
Hyfusin Group Holdings Ltd. Technical Analysis
Negative
0.34
Price Trends
0.37
Negative
0.38
Negative
0.36
Negative
Market Momentum
>-0.01
Positive
47.94
Neutral
54.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8512, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.37, below the 50-day MA of 0.37, and below the 200-day MA of 0.36, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 47.94 is Neutral, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8512.
Hyfusin Group Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$8.45B | 10.49 | 25.77% | 6.65% | 23.19% | -22.44% | |
73 Outperform | HK$330.66M | 3.85 | 11.30% | ― | -0.33% | -37.85% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
46 Neutral | HK$880.92M | -15.33 | -12.81% | 0.53% | 13.43% | 7.72% |
* Consumer Defensive Sector Average
HK:8512
Hyfusin Group Holdings Ltd.
0.36
0.06
20.00%
HK:0157
Natural Beauty Bio-Technology
0.44
-0.09
-16.98%
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
21.12
-70.67
-76.99%
HK:1318
Mao Geping Cosmetics Co., Ltd. Class H
45.86
-50.61
-52.46%
HK:6883
Eternal Beauty Holdings Limited
2.03
-0.06
-2.87%
HK:2657
Shanghai Forest Cabin Cosmetics Group Co., Ltd. Class H
60.00
-20.81
-25.75%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.